NCT02967354View on ClinicalTrials.gov

[11C]5-Hydroxy-tryptophan PET for Assessment of Islet Mass in Type 2 Diabetes

NACompletedINTERVENTIONAL
Enrollment

39

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

October 31, 2015

Study Completion Date

October 31, 2015

Conditions
Type2 Diabetes
Interventions
RADIATION

Positron emission tomography with the tracer [11C]5-hydroxy-tryptophan

Estimation of islet mass by PET using the tracer \[11C\]5-hydroxy-tryptophan

All Listed Sponsors
lead

Per-Ola Carlsson

OTHER

NCT02967354 - [11C]5-Hydroxy-tryptophan PET for Assessment of Islet Mass in Type 2 Diabetes | Biotech Hunter | Biotech Hunter